Loss and Recovery of Genetic Diversity in Adapting Populations of HIV

PLoS Genetics

Volumn 10, Issue 1, 2014, Pages

  Pennings, Pleuni S ^a   Kryazhimskiy, Sergey ^b   Wakeley, John ^c  

^a STANFORD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; LYSINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CODON; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MUTATION RATE; POPULATION SIZE; VIRUS MUTATION; VIRUS PARTICLE;

ADAPTATION, BIOLOGICAL; DRUG RESISTANCE; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENETICS, POPULATION; HIV; HIV INFECTIONS; HUMANS; MUTATION;

EID: 84896691480     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004000     Document Type: Article

References (46)

1. Hayden EJ, Ferrada E, Wagner A, (2011) Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme. Nature 474: 92-95.
2. Lauring AS, Frydman J, Andino R, (2013) The role of mutational robustness in RNA virus evolution. Nat Rev Microbiol 11: 327-336.
3. Maynard Smith J, Haigh J, (1974) The hitchhiking effect of a favorable gene. Genet Res 23: 23-35.
4. Pennings P, Hermisson J, (2006) Soft sweeps II: Molecular population genetics of adaptation from recurrent mutation or migration. Molecular Biology and Evolution 23: 1076-1084.
5. Kouyos RD, Althaus CL, Bonhoeffer S, (2006) Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol 14: 507-511.
6. Leigh-Brown AJ, (1997) Analysis of hiv-1 env gene sequences reveals evidence for a low effective number in the viral population. Proceedings of the National Academy of Sciences of the United States of America 94: 1862-1865.
7. Haase AT, (1994) The role of active and covert infections in lentivirus pathogenesis. Annals of the New York Academy of Sciences 724: 75-86.
8. Coffin JM, (1995) HIV population dynamics in vivo- implications for genetic variation, pathogenesis, and therapy. Science 267: 483-489.
9. Frost SDW, Nijhuis M, Schuurman R, Boucher CAB, Brown AJL, (2000) Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection. Journal of Virology 74: 6262-6268.
10. Rouzine IM, Coffin JM, (1999) Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proceedings of the National Academy of Sciences 96: 10758-10763.
11. Maldarelli (2013) HIV populations are large and accumulate high genetic diversity in nonlinear fashion. J Virol 87: 10313-23 doi: 10.1128/JVI.01225-12.
12. Bacheler LT, Anton ED, Kudish P, Baker D, Bunville J, et al. (2000) Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrobial Agents and Chemotherapy 44: 2475-2484.
13. Karasov T, Messer P, Petrov D, (2010) Evidence that adaptation in drosophila is not limited by mutation at single sites. PLoS Genetics 6: e1000924.
14. Nair S, Nash D, Sudimack D, Jaidee A, Barends M, et al. (2007) Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Molecular Biology and Evolution 24: 562-573.
15. Boltz VF, Ambrose Z, Kearney MF, Shao W, Kewalramani VN, et al. (2012) Ultrasensitive allele-specific PCR reveals rare preexisting drugresistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase. Journal of Virology 86: 12525-30.
16. Kaplan NL, Hudson RR, Langley CH, (1989) The "hitchhiking effect" revisited. Genetics 123: 887-899.
17. Nijhuis M, Boucher Ca, Schipper P, Leitner T, Schuurman R, et al. (1998) Stochastic processes strongly inuence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proceedings of the National Academy of Sciences of the United States of America 95: 14441-6.
18. Pennings P, Hermisson J, (2006) Soft sweeps III: The signature of positive selection from recurrent mutation. PLoS Genetics 2: e186.
19. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH, (2010) Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. Journal of Virology 84: 9864-78.
20. Zhang Y, Imamichi H, Imamichi T, Lane C, J F, et al. (1997) Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its gag substrate cleavage sites. Journal of Virology 71: 6662-6670.
21. Pennings PS, (2012) Standing genetic variation and the evolution of drug resistance in HIV. PLoS Comput Biol 8: e1002527.
22. Sanjuán R, Bordería AV, (2011) Interplay between RNA structure and protein evolution in HIV-1. Molecular Biology and Evolution 28: 1333-8.
23. Song YS, Steinrücken M, (2012) A simple method for finding explicit analytic transition densities of diffusion processes with general diploid selection. Genetics 190: 1117-1129.
24. Alon U (2006) An Introduction to Systems Biology: Design Principles of Biological Circuits. Chapman and Hall/CRC, 1 edition.
25. Malecot G (1969). The Mathematics of Heredity. Revised, edited and translated by D.M. Yermanos.
26. Nei M, Maruyama T, Chakraborty R, (1975) The bottleneck effect and genetic variability in populations. Evolution 29: 1-10.
27. Gordo I, Dionisio F, (2005) Nonequilibrium model for estimating parameters of deleterious mutations. Physical Review E 71: 031907.
28. Lohmueller KE, Indap AR, Schmidt S, Boyko AR, Hernandez RD, et al. (2008) Proportionally more deleterious genetic variation in European than in African populations. Nature 451: 994-U5.
29. Kiezun A, Pulit SL, Francioli LC, van Dijk F, Swertz M, et al. (2013) Deleterious alleles in the human genome are on average younger than neutral alleles of the same frequency. PLoS Genetics 9: e1003301.
30. Desai MM, Fisher DS, (2007) Beneficial mutation-selection balance and the effect of linkage on positive selection. Genetics 176: 1759-1798.
31. Schiffels S, Szöllo{double acute}si GJ, Mustonen V, Lässig M, (2011) Emergent neutrality in adaptive asexual evolution. Genetics 189: 1361-1375.
32. Neher RA, Shraiman BI, (2011) Genetic draft and quasi-neutrality in large facultatively sexual populations. Genetics 188: 975-96.
33. Walczak AM, Nicolaisen LE, Plotkin JB, Desai MM, (2012) The structure of genealogies in the presence of purifying selection: A fitness-class coalescent. Genetics 190: 753-779.
34. Desai MM, Walczak AM, Fisher DS, (2012) Genetic diversity and the structure of genealogies in rapidly adapting populations. Genetics 193: 565-585.
35. Rouzine IM, Coffin JM, (2010) Multi-site adaptation in the presence of infrequent recombination. Theoretical Population Biology 77: 189-204.
36. Rouzine IM, Wakeley J, Coffin JM, (2003) The solitary wave of asexual evolution. Proceedings of the National Academy of Sciences of the United States of America 100: 587-592.
37. Rouzine IM, Brunet E, Wilke CO, (2008) The traveling-wave approach to asexual evolution: Muller's ratchet and speed of adaptation. Theoretical Population Biology 73: 24-46.
38. Neher RA, Shraiman BI, Fisher DS, (2010) Rate of adaptation in large sexual populations. Genetics 184: 467-81.
39. Good BH, Rouzine IM, Balick DJ, Hallatschek O, Desai MM, (2012) Distribution of fixed beneficial mutations and the rate of adaptation in asexual populations. Proceedings of the National Academy of Sciences of the United States of America 109: 4950-5.
40. Goyal S, Balick DJ, Jerison ER, Neher RA, Shraiman BI, et al. (2012) Dynamic mutation-selection balance as an evolutionary attractor. Genetics 191: 1309-1319.
41. Neher RA, Leitner T, (2010) Recombination rate and selection strength in HIV intra-patient evolution. PLoS Computational Biology 6: e1000660.
42. Batorsky R, Kearney MF, Palmer SE, Maldarelli F, Rouzine IM, et al. (2011) Estimate of effective recombination rate and average selection coef- ficient for HIV in chronic infection. Proceedings of the National Academy of Sciences of the United States of America 108: 5661-5666.
43. Mullins JI, Heath L, Hughes JP, Kicha J, Styrchak S, et al. (2011) Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461. PLoS One 6: e15135.
44. Weissman DB, Barton NH, (2012) Limits to the rate of adaptive substitution in sexual populations. PLoS Genetics 8: e1002740.
45. Johnson V, Brun-Vézinet F, Clotet B, Günthard H, Kuritzkes D, et al. (2010) Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med 18: 156-163.
46. Mansky LM, Temin HM, (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. Journal of Virology 69: 5087-94.